Legacy Of Many Sponsors Complicated Review Of Vanda's Fanapt

The multiple sponsors of the antipsychotic Fanapt (iloperidone) produced an inconsistent development program followed by a tumultuous and ultimately dramatic review as FDA worked through a succession of issues surrounding clinical trial design and analysis choices.